Publication

Current Status of Transcranial Direct Current Stimulation in Posttraumatic Stress and Other Anxiety Disorders

Downloadable Content

Persistent URL
Last modified
  • 03/14/2025
Type of Material
Authors
    Benjamin M. Hampstead, VA Ann Arbor Healthcare SystemEmily M. Briceño, University of MichiganNathan Andrew Mascaro, Emory UniversityAndoni Mourdoukoutas, The City College of New York of CUNYMarom Bikson, The City College of New York of CUNY
Language
  • English
Date
  • 2016-06
Publisher
  • Springer Verlag (Germany)
Publication Version
Copyright Statement
  • © Springer International Publishing AG (outside the USA) 2016
Final Published Version (URL)
Title of Journal or Parent Work
ISSN
  • 2196-2979
Volume
  • 3
Issue
  • 2
Start Page
  • 95
End Page
  • 101
Grant/Funding Information
  • This work was supported by the National Institute of Mental Health (1R21MH102539-01 to BMH).
Abstract
  • Several empirically supported treatments have been identified for post-traumatic stress disorder (PTSD), yet a sizable number of patients are either unable to tolerate these approaches or remain symptomatic following treatment. Transcranial direct current stimulation (tDCS) is a well-tolerated method of modulating neuronal excitability that may hold promise as a novel intervention in PTSD and related disorders. The current review summarizes literature on the disrupted neural circuitry in PTSD and discusses the rationale for the commonly targeted prefrontal cortex (PFC) as it relates to PTSD. We then review the few prior (case) studies that have evaluated tDCS in patients with PTSD (1 study) and other anxiety disorders (4 studies). There was considerable variability in both the methods/justification for selecting the targeted brain region(s) and the tDCS montage used, which obscured any clear trends in the data. Finally, we describe the rationale for our ongoing study that specifically targets the lateral temporal cortex as a method of treating the symptoms of hyperarousal and re-experiencing in PTSD. Overall, it is clear that additional work is needed to establish dosing (e.g., intensity and duration of sessions, number of sessions) and optimal treatment targets as well as to identify synergistic effects with existing treatments.
Author Notes
  • Benjamin M. Hampstead, PhD, ABPP/CN, Neuropsychology Section, Department of Psychiatry, University of Michigan, 2101 Commonwealth Blvd, Suite C, Ann Arbor, MI 48105, USA, Phone: 734-763-9259, Fax: 734-936-9262,
Keywords
Research Categories
  • Psychology, Behavioral

Tools

Relations

In Collection:

Items